Cargando…

The premarket assessment of the cost-effectiveness of a predictive technology “Straticyte™” for the early detection of oral cancer: a decision analytic model

INTRODUCTION: Approximately half of oral cancers are detected in advanced stages. The current gold standard is histopathological assessment of biopsied tissue, which is subjective and dependent on expertise. Straticyte™, a novel prognostic tool at the pre-market stage, that more accurately identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoudigian-Sinani, S., Blackhouse, G., Levine, M., Thabane, L., O’Reilly, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624864/ https://www.ncbi.nlm.nih.gov/pubmed/28971373 http://dx.doi.org/10.1186/s13561-017-0170-6

Ejemplares similares

Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations
por: Khoudigian-Sinani, Shoghag, et al.
Publicado: (2017)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Premarket Safety and Efficacy Studies for ADHD Medications in Children
por: Bourgeois, Florence T., et al.
Publicado: (2014)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval
por: Matsushita, Shunsuke, et al.
Publicado: (2021)

Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations
por: Tsoi, B, et al.
Publicado: (2015)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
por: Blackhouse, Gord, et al.
Publicado: (2013)

Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography
por: Aponte Ortiz, Jaime A., et al.
Publicado: (2018)

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021)

Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
por: Iijima, Kazuo, et al.
Publicado: (2016)

Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021)

Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee
por: Sauerland, Stefan, et al.
Publicado: (2019)

Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
por: Lee, Samuel J., et al.
Publicado: (2021)

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019)

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports
por: Chang, Lee, et al.
Publicado: (2015)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
por: Dubin, Jonathan R., et al.
Publicado: (2021)

Assessing Visual Outcomes: A Comparative Study of US-FDA Premarket Approval Data for Multifocal and EDOF Lens Implants in Cataract Surgery
por: Moshirfar, Majid, et al.
Publicado: (2023)

Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
por: Mirzayeh Fashami, Fatemeh, et al.
Publicado: (2023)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Decision analytic model exploring the cost and cost-offset implications of street triage
por: Heslin, Margaret, et al.
Publicado: (2016)

The Role of decision-analytic modelling in German health technology assessments
por: Kuhlmann, Alexander, et al.
Publicado: (2015)

Cost-effectiveness analysis of a community paramedicine programme for low-income seniors living in subsidised housing: the community paramedicine at clinic programme (CP@clinic)
por: Agarwal, Gina, et al.
Publicado: (2020)

Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model
por: Schmier, Jordana K, et al.
Publicado: (2014)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

21 Technologies for the 21st Century
por: O'Reilly, Tim
Publicado: (2020)

Playing-Side Analytics in Team Sports: Multiple Directions, Opportunities, and Challenges
por: Foster, George, et al.
Publicado: (2021)

Network storage: tools and technologies for storing your company's data
por: O'Reilly, James
Publicado: (2017)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Low Cost Technology for Screening Early Cancerous Lesions of Oral Cavity in Rural Settings
por: Parashari, A, et al.
Publicado: (2014)

Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
por: Bakır, Mustafa, et al.
Publicado: (2012)

Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model
por: Okafor, Charles E., et al.
Publicado: (2017)

Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models
por: Sanghera, Sabina, et al.
Publicado: (2018)

Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach
por: Nazir, Muhummad Sohaib, et al.
Publicado: (2022)

State-change decisions and dorsomedial prefrontal cortex: the importance of time
por: Kolling, Nils, et al.
Publicado: (2018)

Effects of study design and trends for EVAR versus OSR
por: Hopkins, Robert, et al.
Publicado: (2008)

Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada
por: O’Reilly, Daria J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8hka3gd162mhki116amvi9ojuj